{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:18:04Z","timestamp":1793852284187,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007055","name":"Third Military Medical University","doi-asserted-by":"publisher","award":["2022-JCJQ-QT-004"],"award-info":[{"award-number":["2022-JCJQ-QT-004"]}],"id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007055","name":"Third Military Medical University","doi-asserted-by":"publisher","award":["CX2019LC121"],"award-info":[{"award-number":["CX2019LC121"]}],"id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007055","name":"Third Military Medical University","doi-asserted-by":"publisher","award":["XZ-2019-505-005"],"award-info":[{"award-number":["XZ-2019-505-005"]}],"id":[{"id":"10.13039\/501100007055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172489"],"award-info":[{"award-number":["82172489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xcrm.2023.101165","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T10:27:23Z","timestamp":1692613643000},"page":"101165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Osteoclast-derived apoptotic bodies inhibit naive CD8+ T\u00a0cell activation via Siglec15, promoting breast cancer secondary metastasis"],"prefix":"10.1016","volume":"4","author":[{"given":"Yutong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiulin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-6354","authenticated-orcid":false,"given":"Ce","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101165_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.xcrm.2023.101165_bib2","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.cell.2021.03.011","article-title":"The bone microenvironment invigorates metastatic seeds for further dissemination","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2023.101165_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","article-title":"Endocrine aspects of bone metastases","volume":"2","author":"Hofbauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xcrm.2023.101165_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/jamaoncol.2021.1854","article-title":"Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial","volume":"7","author":"Friedl","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib5","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","article-title":"Cellular and molecular mechanisms of bone remodeling","volume":"285","author":"Raggatt","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101165_bib6","doi-asserted-by":"crossref","first-page":"11240","DOI":"10.1074\/jbc.RA119.007625","article-title":"Mature osteoclast-derived apoptotic bodies promote osteogenic differentiation via RANKL-mediated reverse signaling","volume":"294","author":"Ma","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101165_bib7","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.7150\/thno.45170","article-title":"Osteoclast-derived apoptotic bodies show extended biological effects of parental cell in promoting bone defect healing","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2023.101165_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41413-020-00121-1","article-title":"Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling","volume":"9","author":"Ma","year":"2021","journal-title":"Bone Res"},{"key":"10.1016\/j.xcrm.2023.101165_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T\u00a0cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2023.101165_bib10","article-title":"CD8(+) T\u00a0cell immunity blocks the metastasis of carcinogen-exposed breast cancer","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2023.101165_bib11","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/annonc\/mdu191","article-title":"Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients","volume":"25","author":"Ali","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib12","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00432-019-03036-5","article-title":"Tumor-infiltrating lymphocytes and CD8(+) T\u00a0cells predict survival of triple-negative breast cancer","volume":"145","author":"Vihervuori","year":"2019","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10549-014-3185-2","article-title":"The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis","volume":"148","author":"Ibrahim","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.xcrm.2023.101165_bib14","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study","volume":"34","author":"Nanda","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101165_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41413-022-00186-0","article-title":"Sialylation of TLR2 initiates osteoclast fusion","volume":"10","author":"Dou","year":"2022","journal-title":"Bone Res"},{"key":"10.1016\/j.xcrm.2023.101165_bib17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.176.6.1645","article-title":"Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci","volume":"176","author":"Watson","year":"1992","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101165_bib18","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1021\/acs.jproteome.7b00625","article-title":"Identification of Siglec Ligands Using a Proximity Labeling Method","volume":"16","author":"Chang","year":"2017","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.xcrm.2023.101165_bib19","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood-2010-02-268169","article-title":"When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function","volume":"116","author":"Geng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101165_bib20","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1073\/pnas.0400171101","article-title":"TLR2 is expressed on activated T\u00a0cells as a costimulatory receptor","volume":"101","author":"Komai-Koma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101165_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41573-020-00093-1","article-title":"The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans","volume":"20","author":"Smith","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101165_bib22","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2023.101165_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101165_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nrclinonc.2010.134","article-title":"Future directions of bone-targeted therapy for metastatic breast cancer","volume":"7","author":"Onishi","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070218","article-title":"The Osteoclast in Bone Metastasis: Player and Target","volume":"10","author":"Maurizi","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2023.101165_bib26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jbo.2016.02.008","article-title":"The role of osteoclasts in breast cancer bone metastasis","volume":"5","author":"Le Pape","year":"2016","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.xcrm.2023.101165_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1470-2045(18)30862-3","article-title":"Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Gnant","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(15)60908-4","article-title":"Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials","volume":"386","author":"Early Breast Cancer Trialists' Collaborative","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2023.101165_bib29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"issue":"Suppl 2","key":"10.1016\/j.xcrm.2023.101165_bib30","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","article-title":"Bisphosphonates: mode of action and pharmacology","volume":"119","author":"Russell","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.xcrm.2023.101165_bib31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-19-2925","article-title":"Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy","volume":"27","author":"Sun","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101165_bib32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40364-022-00369-1","article-title":"The intriguing roles of Siglec family members in the tumor microenvironment","volume":"10","author":"Jiang","year":"2022","journal-title":"Biomark Res"},{"key":"10.1016\/j.xcrm.2023.101165_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-019-0610-1","article-title":"Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases","volume":"27","author":"Angata","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.xcrm.2023.101165_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.20892\/j.issn.2095-3941.2018.0141","article-title":"Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle","volume":"16","author":"Ren","year":"2019","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.xcrm.2023.101165_bib35","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4049\/jimmunol.1801026","article-title":"Costimulation through TLR2 Drives Polyfunctional CD8(+) T Cell Responses","volume":"202","author":"Salerno","year":"2019","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101165_bib36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri3095","article-title":"TLR-dependent T\u00a0cell activation in autoimmunity","volume":"11","author":"Mills","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101165_bib37","first-page":"E8698","article-title":"Adjuvant effect of the novel TLR1\/TLR2 agonist Diprovocim synergizes with anti-PD-L1 to eliminate melanoma in mice","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101165_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","article-title":"Targeting Toll-like receptors: emerging therapeutics?","volume":"9","author":"Hennessy","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101165_bib39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/glycob\/cwv097","article-title":"Sialic acids in cancer biology and immunity","volume":"26","author":"Pearce","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.xcrm.2023.101165_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41416-020-01126-7","article-title":"Insights into the role of sialylation in cancer progression and metastasis","volume":"124","author":"Dobie","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2023.101165_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092014","article-title":"Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?","volume":"13","author":"Pietrobono","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2023.101165_bib42","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fonc.2015.00219","article-title":"The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control","volume":"5","author":"Kolbl","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2023.101165_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/157340611796799230","article-title":"Salivary total sialic acid levels increase in breast cancer patients: a preliminary study","volume":"7","author":"Ozturk","year":"2011","journal-title":"Med. Chem."},{"key":"10.1016\/j.xcrm.2023.101165_bib44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bjc.1980.101","article-title":"Serum sialic acid and CEA concentrations in human breast cancer","volume":"41","author":"Hogan-Ryan","year":"1980","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2023.101165_bib45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14789450.2019.1645604","article-title":"Glycosylation and its implications in breast cancer","volume":"16","author":"Scott","year":"2019","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.xcrm.2023.101165_bib46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.biochem.76.061005.092322","article-title":"Glycosyltransferases: structures, functions, and mechanisms","volume":"77","author":"Lairson","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.xcrm.2023.101165_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-019-0500-x","article-title":"Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin alpha5beta1 interaction and Akt signaling pathway","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.xcrm.2023.101165_bib48","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3389\/fimmu.2018.00957","article-title":"Tumor-Derived Apoptotic Vesicles: With Death They Do Part","volume":"9","author":"Muhsin-Sharafaldine","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101165_bib49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3389\/fimmu.2017.01174","article-title":"Extracellular Vesicles Arising from Apoptotic Cells in Tumors: Roles in Cancer Pathogenesis and Potential Clinical Applications","volume":"8","author":"Lynch","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101165_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccell.2018.05.012","article-title":"Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors","volume":"34","author":"Pavlyukov","year":"2018","journal-title":"Cancer Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912300318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912300318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:57:09Z","timestamp":1762988229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912300318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S266637912300318X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101165","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoclast-derived apoptotic bodies inhibit naive CD8+ T\u00a0cell activation via Siglec15, promoting breast cancer secondary metastasis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101165"}}